Thomas Silvers

572 total citations
14 papers, 334 citations indexed

About

Thomas Silvers is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Thomas Silvers has authored 14 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Thomas Silvers's work include Protein Degradation and Inhibitors (3 papers), Cancer Research and Treatments (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). Thomas Silvers is often cited by papers focused on Protein Degradation and Inhibitors (3 papers), Cancer Research and Treatments (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). Thomas Silvers collaborates with scholars based in United States, Malaysia and Ukraine. Thomas Silvers's co-authors include Beverly A. Teicher, David M. Evans, Julie Laudeman, René Delosh, Russell Reinhart, John Connelly, Mark W. Kunkel, Michael Selby, Jeffrey K. Myers and Erik Harris and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Biochemistry and Cancer Research.

In The Last Decade

Thomas Silvers

13 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Silvers United States	7	198	177	61	54	49	14	334
Julie Laudeman United States	6	184 0.9×	162 0.9×	56 0.9×	43 0.8×	49 1.0×	9	313
Russell Reinhart United States	6	181 0.9×	168 0.9×	61 1.0×	46 0.9×	47 1.0×	9	298
René Delosh United States	7	205 1.0×	190 1.1×	83 1.4×	41 0.8×	78 1.6×	10	347
Axel-Rainer Hanauske Germany	8	266 1.3×	209 1.2×	88 1.4×	65 1.2×	58 1.2×	17	494
Lanya Li China	7	285 1.4×	132 0.7×	45 0.7×	68 1.3×	79 1.6×	12	433
Kaamar Azijli Netherlands	10	325 1.6×	161 0.9×	53 0.9×	43 0.8×	106 2.2×	13	465
Emily J. Lelliott Australia	9	181 0.9×	195 1.1×	43 0.7×	22 0.4×	25 0.5×	10	337
Vojo Vukovic United States	7	277 1.4×	125 0.7×	99 1.6×	28 0.5×	81 1.7×	13	440
Derek P. Logsdon United States	8	455 2.3×	147 0.8×	46 0.8×	38 0.7×	98 2.0×	15	571
Hyo-Eun Carrie Bhang United States	6	204 1.0×	118 0.7×	69 1.1×	13 0.2×	49 1.0×	7	364

Countries citing papers authored by Thomas Silvers

Since Specialization

Citations

This map shows the geographic impact of Thomas Silvers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Silvers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Silvers more than expected).

Fields of papers citing papers by Thomas Silvers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Silvers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Silvers. The network helps show where Thomas Silvers may publish in the future.

Co-authorship network of co-authors of Thomas Silvers

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Silvers. A scholar is included among the top collaborators of Thomas Silvers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Silvers. Thomas Silvers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Dexheimer, Thomas S., Nathan P. Coussens, Thomas Silvers, et al.. (2025). Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids. SLAS DISCOVERY. 32. 100222–100222. 2 indexed citations

Teicher, Beverly A., Thomas S. Dexheimer, Li Chen, et al.. (2025). Polymerase Ѳ inhibitors combinations with approved and investigational agents in patient-derived tumor multi-cell type (mct) spheroids. Experimental and Molecular Pathology. 143. 104978–104978. 1 indexed citations

Coussens, Nathan P., Thomas S. Dexheimer, Eric M. Jones, et al.. (2024). Abstract 3090: Development and performance of the National Cancer Institute’s HTS384 NCI60 screen: A modernized platform to support drug discovery and development by the worldwide cancer research community. Cancer Research. 84(6_Supplement). 3090–3090. 1 indexed citations

Dexheimer, Thomas S., Thomas Silvers, Nathan P. Coussens, et al.. (2024). Abstract 4608: Combinations of Cdc-like kinase (CLK) inhibitors with targeted oncology agents or standard chemotherapy in patient-derived multi-cell type tumor spheroids. Cancer Research. 84(6_Supplement). 4608–4608.

Zabinsky, Rebecca, et al.. (2022). A Stress Response that Allows Highly Mutated Eukaryotic Cells to Survive and Proliferate. SSRN Electronic Journal. 1 indexed citations

Krushkal, Julia, Thomas Silvers, William C. Reinhold, et al.. (2020). Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets. Clinical Epigenetics. 12(1). 93–93. 50 indexed citations

Evans, David M., Jianwen Fang, Thomas Silvers, et al.. (2019). Exposure time versus cytotoxicity for anticancer agents. Cancer Chemotherapy and Pharmacology. 84(2). 359–371. 22 indexed citations

Delosh, René, Julie Laudeman, Russell Reinhart, et al.. (2017). 3D Models of the NCI60 Cell Lines for Screening Oncology Compounds. SLAS DISCOVERY. 22(5). 473–483. 55 indexed citations

Teicher, Beverly A., Thomas Silvers, Michael Selby, et al.. (2017). Small cell lung carcinoma cell line screen of etoposide/carboplatin plus a third agent. Cancer Medicine. 6(8). 1952–1964. 16 indexed citations

10.

Polley, Eric C., Mark W. Kunkel, David M. Evans, et al.. (2016). Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression. JNCI Journal of the National Cancer Institute. 108(10). djw122–djw122. 106 indexed citations

11.

Teicher, Beverly A., Eric C. Polley, Mark W. Kunkel, et al.. (2015). Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression. Molecular Cancer Therapeutics. 14(11). 2452–2462. 55 indexed citations

12.

Silvers, Thomas & Jeffrey K. Myers. (2013). Osmolyte Effects on the Self-Association of Concanavalin A: Testing Theoretical Models. Biochemistry. 52(51). 9367–9374. 23 indexed citations

13.

August, Elias, René Delosh, Julie Laudeman, et al.. (2013). Abstract 5590: Screening of pediatric and adult sarcoma cell lines reveals novel patterns of sensitivity toward approved oncology drugs and investigational agents.. Cancer Research. 73(8_Supplement). 5590–5590. 1 indexed citations

14.

Monks, Anne, David M. Evans, Thomas Silvers, et al.. (2013). Abstract C103: Sarcoma cell line sensitivity towards approved oncology drugs and investigational agents identifies distinct patterns of response which can be interrogated with associated gene expression.. Molecular Cancer Therapeutics. 12(11_Supplement). C103–C103. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact